Related references
Note: Only part of the references are listed.Clinical Trial Drug Safety Assessment With Interactive Visual Analytics
Wei Wang et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2021)
Guidelines for Reporting of Figures and Tables for Clinical Research in Urology
Andrew J. Vickers et al.
EUROPEAN UROLOGY (2020)
Understanding current practice, identifying barriers and exploring priorities for adverse event analysis in randomised controlled trials: an online, cross-sectional survey of statisticians from academia and industry
Rachel Phillips et al.
BMJ OPEN (2020)
Advantages of visualisations to evaluate and communicate adverse event information in randomised controlled trials
Victoria Cornelius et al.
TRIALS (2020)
Statistical Practices of Safety Monitoring: An Industry Survey
Michael W. Colopy et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2019)
Analysis and reporting of adverse events in randomised controlled trials: a review
Rachel Phillips et al.
BMJ OPEN (2019)
Proposals on Kaplan-Meier plots in medical research and a survey of stakeholder views: KMunicate
Tim P. Morris et al.
BMJ OPEN (2019)
Effective Visual Communication for the Quantitative Scientist
Marc Vandemeulebroecke et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Guidelines for the Content of Statistical Analysis Plans in Clinical Trials
Carrol Gamble et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254
Gita Thanarajasingam et al.
LANCET ONCOLOGY (2016)
Analysing adverse events by time-to-event models: the CLEOPATRA study
Tanja Proctor et al.
PHARMACEUTICAL STATISTICS (2016)
Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective
Neil Lineberry et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective
Neil Lineberry et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Seeing is believing: good graphic design principles for medical research
Susan P. Duke et al.
STATISTICS IN MEDICINE (2015)
Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved
Jennifer K. Rogers et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
The Practice of Pre-Marketing Safety Assessment in Drug Development
Christy Chuang-Stein et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2013)
Drug safety assessment in clinical trials: methodological challenges and opportunities
Sonal Singh et al.
TRIALS (2012)
Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team
Brenda J. Crowe et al.
CLINICAL TRIALS (2009)
Graphical approaches to the analysis of safety data from clinical trials
Ohad Amit et al.
PHARMACEUTICAL STATISTICS (2008)
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Michael J. Bradburn et al.
STATISTICS IN MEDICINE (2007)
Survival ratio plots with permutation envelopes in survival data problems
J Newell et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2006)
Better reporting of harms in randomized trials: An extension of the CONSORT statement
JPA Ioannidis et al.
ANNALS OF INTERNAL MEDICINE (2004)
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data
MJ Sweeting et al.
STATISTICS IN MEDICINE (2004)
Let's practice what we preach: Turning tables into graphs
A Gelman et al.
AMERICAN STATISTICIAN (2002)
Share Paper
